Pacira | PCRX - Ativo Circulante





Ativo Circulante Alterar Data
Assertio Holdings USD 263.57M 53.36M 2025-09
Astellas Pharma JPY 1.42T 19.35B 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Cara Therapeutics USD 38.44M 4.69M 2025-09
Coherus Biosciences USD 206.71M 254.25M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
J&J USD 59.17B 3.55B 2026-03
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 42.82B 76M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12
Xoma USD 110.71M 5.78M 2025-09
Zoetis USD 6.77B 185M 2025-12